At #ASTRO26, we are proud to welcome so many Yale attendees, including our current residents and the alumni of our Radiation Oncology Residency Program, and advancing the field of radiation oncology. @astro-org.bsky.social @oncoalert.bsky.social

At #ASTRO26 Dr. Cary Gross @carygross.bsky.social presented on Comparative Effectiveness and Value in Cancer Care, exploring how we measure and communicate the value of #radiationoncology and #cancercare. @astro-org.bsky.social @oncoalert.bsky.social

Can Brain #MRI Surveillance Alone Be Advantageous in Monitoring Cognition for Patients with SCLC?
www.diagnosticimaging.com/view/brain-m...
#radiology #RadRes #ASTRO26

Late-breaking news from #ASTRO26: Alliance for Clinical Trials in Oncology Phase III trial (A071801) finds 3-5 sessions of radiosurgery after surgery for large brain metastases outperforms single-session treatment in reducing local recurrence and boosting survival. https://bit.ly/ASTRO26

TODAY AT #ASTRO26 - NRG leaders Dr. Sandler, Dr. Higgins, and Dr. Gondi will be discussing the ins and outs of clinical trial design though accrual during the Developing, Activating & Operating Clinical Trials session at 3PM in Room 259

Dr. Shari Damast presented "Advanced #EndometrialCancer Case Discussion - The Significance of Molecular Status" in an #ASTRO26 Education Session this morning.
amportal.astro.org/sessions/edu-2…
@astro-org.bsky.social

Today at #ASTRO26, Adi Robinson demonstrated how the MacroMedics DSPS-Prominent system and AlignRT can work together to bring greater precision and patient comfort to the treatment experience.

Visit booth #2229 to see how maskless head & neck treatment is a clinical reality with SGRT.

What a night! 🥂

We rolled out the red carpet at The State Room last night to mark 25 years of SGRT leadership, celebrate our incredible journey, and toast to what’s next.

Thank you to everyone who joined us. The celebration continues at booth #2229! #ASTRO26

In Collaboration with our partners at ASTRO we continue our coverage of #ASTRO26 🚨

SIX-YEAR OVERALL SURVIVAL OF NIVOLUMAB FOLLOWING STEREOTACTIC ABLATIVE RADIOTHERAPY IN EARLY-STAGE NON-SMALL CELL LUNG CANCER: RANDOMIZED I-SABR TRIAL

Presented by Dr. Joe Chang🇺🇸

Today at #ASTRO26, we have two AM and two PM poster presentations scheduled in Exhibit Hall A. Please stop by and support your colleagues and their research: Drs. Dae Han; Anvi Sud; James Ninia; and Erica Shen.
@astro-org.bsky.social

We're back for Day 3 at #ASTRO26 in Boston. Here's who's presenting today from @washumedicine.bsky.social and Siteman Cancer Center. #ASTRO26

If you are attending the #ASTRO26 Plenary Session, be sure to look for results on NRG-GI003 and NRG-CC009! We will be discussing these results on the NRG Oncology Podcast after the session! www.NRGOncology.org/Podcast

SEVEN NRG presentations are at various sessions today at #ASTRO26 covering a variety of disease sites. You can see all of our NRG presentations in our flyer here: https://ow.ly/WyYR50ZPIMw

In Collaboration with our partners at ASTRO we continue our coverage of #ASTRO26 🚨

LBA 03 - SWOG S1827/MAVERICK: A RANDOMIZED PHASE III TRIAL OF BRAIN MRI SURVEILLANCE WITH AND WITHOUT PROPHYLACTIC CRANIAL IRRADIATION (PCI) FOR SMALL-CELL LUNG CANCER (SCLC)

Presented by Dr. Paul Brown 🇺🇸

Today at #ASTRO26: MSK radiation oncologist Dr. Alexander Goglia will present five-year outcomes from a trial of MR-guided SBRT with a focal DIL boost for intermediate-risk prostate cancer.

🗓️ Monday, September 28 | 3:10 p.m. ET

Learn more: https://bit.ly/47lXHPT

De. Henry Park at #ASTRO26: How should we interpret randomized Phase II trials in radiation oncology? Dr. Park reviewed the potential impact of phase II clinical trials, while reviewing the need for scrutiny of results. @astro-org.bsky.social @oncoalert.bsky.social

Dr. James Ninia shares a case series of early radium therapy from the #YNHH archives, the birth of modern #brachytherapy, at #ASTRO26. @astro-org.bsky.social @oncoalert.bsky.social
amportal.astro.org/sessions/pqa-0…

Dr. Shari Bodofsky shares research #ASTRO26 showing women <45 with rectal cancer who undergo pelvic radiation face early menopause.
Early counseling on fertility preservation and hormone therapy improve outcomes. @astro-org.bsky.social @oncoalert.bsky.social

This morning in Room 256 at #ASTRO26, @carygross.bsky.social presents "Comparative Effectiveness and Value in Cancer Care" as part of an Education Session. amportal.astro.org/sessions/edu-1…
@astro-org.bsky.social

Predetermined Change Control Plan Adoption and Documentation Transparency in U.S. Food and Drug Administration–cleared Radiology Artificial Intelligence/Machine Learning Devices https://doi.org/10.1148/ryai.260385 #ASTRO26 #RadOnc #OncoRad #radiology